Wade Walke | SVP, IR |
Brett Monia | CEO |
Richard Geary | Chief Development Officer |
Beth Hougen | CFO |
Onaiza Cadoret | Chief Global Product Strategy & Operations Officer |
Eugene Schneider | Chief Clinical Development Officer |
Eric Swayze | EVP, Research |
Myles Minter | William Blair |
Robert Finke | Guggenheim Partners |
Kostas Biliouris | BMO Capital Markets |
Mike Ulz | Morgan Stanley |
Yanan Zhu | Wells Fargo |
David Lebowitz | Citigroup Inc. |
Allison Bratzel | Piper Sandler |
Paul Matteis | Stifel |
Yaron Werber | TD Cowen |
Luca Issi | RBC Capital Markets |
Yale Jen | Laidlaw & Company |
Joseph Stringer | Needham & Company |
Good morning, and welcome to Ionis' Second Quarter 2023 Financial Results Conference Call.
As a reminder, this call is being recorded.
At this time, I would like to turn the call over to Wade Walke, Senior Vice President of Investor Relations, to lead off the call. Please begin.
Thank you, MJ.